Managing Director MD.DGO
Consultant Gynaecologist and obstetrician Gynaecologist Counseller
CEO MD. DGO
Consultant Gynaecologist and obstetrician
Donec ullamcorper nulla non metus auctor fringilla. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Aenean eu leo quam. Pellentesque ornare sem lacinia quam. Nulla vitae elit libero, a pharetra.
Miscarriages/Repeated Miscarriages are amongst one of the most shattering experiences, a woman can go through. Statistics have shown that 25% of all pregnancies result in miscarriages.
In Vitro Fertilization (IVF) is an Assisted Reproductive Technology, used in the treatment of Infertility. This involves taking out of the eggs from the ovaries, and fertilizing them with sperms in the laboratory.
Immunomodulation can play an important role in these patiets. Immunomodulatio can be done with Active or Passive Immunotherapy. Immunotherapy can help prevent the Immunological rejection of pregnancy.
ICPRM offers Immunotherapy Treatment to prevent recurrent miscarraiages. When a woman suffers from 2 or more miscarriages, it is termed as Repeated or Recurrent Miscarriages.
Lymphocyte immunization Therapy holds much potential as a safe and effective treatment approach for patients who have failed IVF or repeated miscarriages.
Immunological response plays a very important role in maintenance of pregnancy. Many theories have been put forward to explain the mechanisms that help to protect pregnancy. Many allo-immune mechanisms have been described to explain the immunomodulatory effects of LIT. These mechanisms together or individually act on the feto-maternal interface to induce complex events preventing allo-immune rejection of pregnancy.
– High Success ratio
– No long term side effects
– Easy Treatment
– Safe procedure
– Single seating
– Researched & patented technology
Total of 596 couples were given Immunotherapy, 486 patients with
Recurrent Miscarriages or unexplained infertility and 110 patients with IVF
Of the 486 with RM, 390 women conceived and delivered live fetus at 33 weeks or later.
Of the 110 patients with IVF failure 85 conceived & delivered at 33
weeks or later
As LIT involves separation and injection of blood component (lymphocytes), establishing complete safety is important.
Systemic side effects : No systemic long term side effects have been reported. In 2006, Kling led large European studies, each involving over 4000 patients over a three year time span using LIT techniques. No anaphylaxis, autoimmune reactions or graft versus host disease were reported.
The safety issue that is commonly raised is transmission of infections, but with complete infection profile work-up of both the partners eliminates this risk.
Mr Mukri who could not attend the programme due to some prior engagements, said he took his wife to several doctors but to no avail. “My wife had 14-15 miscarriages before, with no living child. I went from one hospital to another and was despairing as I saw my wife undergo 14 to 15 miscarriages. I had lost all hopes of having a baby when, a gynecologist suggested me the name of Dr. Raut and that worked”. I am a proud father of a healthy daughter today. I am eternally thankful to Dr. Raut”
Dear Dr Raut,
Hope u r fine. First let me share our happiness with u just because of gods grace and with ur excellent medical treatment our little boy was born yesterday morning at 37 weeks. Sorry for this late mail I was suppose to do do the video last week. But we were going through a tough time I was admitted in hospital they told me baby is iugr and need to keep close eye on baby not gaining any weight for 3 weeks. so they induced me yesterday and baby is fine he is only 2 kilos but everything else is fine.
No words to say my thanks to u . I do want to take part in your LIT treatment . will do the video to help someone else who is going through tough time like me for years. I will send u photographs of baby no name yet. Thank u so much. Regards to everyone.